Priority Date: 30.03.10 (JP 20100078772)

PROGNOSTIC METHOD FOR PULMONARY ADENOCARCINOMA, PULMONARY ADENOCARCINOMA DETECTION KIT, AND PHARMACEUTICAL COMPOSITION FOR TREATING PULMONARY ADENOCARCINOMA

  • Application ID: EP11762858
  • Status: PATENT GRANTED

Attorney

Employment test 51 - 200 employees
Company dna epping hermann fischer patentanwaltsgesellschaft mbh
operating since 1999
Headquarter in Munich and 1 office
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This EP application has the IPC class A61, C12, and G01. We found, that TransMIT GmbH, Kailuweit & Uhlemann, dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB, Avidity IP Ltd, Mewburn Ellis LLP and 77 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 30.03.2010 - Priority Date (JP 20100078772)
  • 06.10.2011 - Publication A1 (WO2011122634)
  • 13.02.2013 - Publication A1 (EP2557159)
  • 24.08.2016 - Publication B1 (EP2557159)